ArticleBMC cancer2022

Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes.

Defeng Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.